March 25 (Reuters) - Oasmia Pharmaceutical AB OASM.ST :
* ANNOUNCED ON WEDNESDAY THAT AN ARBITRAL TRIBUNAL IN
STOCKHOLM,
SWEDEN, HAS UPHELD OASMIA’S RIGHT TO RECORD THE ASSIGNMENT OF
ITS PATENTS AND PATENT APPLICATIONS IN ITS OWN NAME
* THE ARBITRAL TRIBUNAL ALSO AWARDED ALL OF OASMIA’S COSTS
RELATED
TO THE LEGAL DISPUTE TO BE BORNE BY ARDENIA INVESTMENTS
Source text for Eikon: urn:newsml:reuters.com:*:nMFNbG6rZ3
Further company coverage: OASM.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))